# Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir

> **NCT02707198** · PHASE2 · TERMINATED · sponsor: **St. Luke's Hospital of Duluth** · enrollment: 2 (actual)

## Conditions studied

- Clostridium Difficile Infection
- Diarrhea

## Interventions

- **DRUG:** kefir

## Key facts

- **NCT ID:** NCT02707198
- **Lead sponsor:** St. Luke's Hospital of Duluth
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was not feasible to complete at study site
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707198, "Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02707198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*